Printable version: Chronic Kidney Disease – full article
Interest in the dietary treatment of chronic kidney disease has been growing as its incidence has been increasing. Chronic Kidney Disease (CKD) is now the 8th leading cause of death in the United States and its treatment consumes substantial amounts of medical resources and money.
Several lines of epidemiological research have shown a lower risk of chronic kidney disease among vegetarians. It also shows a substantially increased risk among omnivores, especially those who eat red and processed meats.
Although the practice started long ago, research on the use of a low-protein plant-based diet to treat chronic kidney disease diet has intensified in recent years. This research has shown that a low-protein vegetarian diet is safe and efficacious at both treating and slowing the progression of chronic kidney disease.
Treatment with a low-protein vegetarian diet, often supplemented with keto analogues, has been shown to reduce acidosis, phosphotemia, uremia, proteinuria and to slow progression. Research shows that this treatment does not result in malnutrition. Research has also shown that larger amounts of plant protein than animal protein can be consumed, without deleterious effects.
Treatment with a low protein vegetarian diet also has the advantage of preventing and treating common comorbidities such as type 2 diabetes and coronary artery disease.
Vitamin B12 is a water-soluble vitamin that is naturally present in animal-derived foods. It is added to others and is available as a dietary supplement and a prescription medication. Vitamin B12 exists in several forms and contains the mineral cobalt, (1, 2, 3, 4) so compounds with vitamin B12 activity are collectively called “cobalamins”. Methylcobalamin and 5-deoxyadenosylcobalamin are the forms of vitamin B12 that are active in human metabolism. (5) Continue reading
Prevention and Treatment of Disease with a Plant-Based Diet
was held on Saturday, April 7, 2018, Time: 6:30pm – 9pm
at the Seattle Center Exhibition Hall on Mercer Street, Seattle.
Given by medical doctors, for the benefit of medical doctors and medical students.
Videos of the talks given at this seminar are now available. Click on each title in the Schedule below to see an individual talk, or click on the video link below the Schedule to see the whole seminar.
This year’s speakers included:
- Dr Helmuth Fritz – Internal Medicine
- Dr Chan Hwang – Physiatrist
- Dr George Lee – Family Medicine
- Dr Uma Krishnan – Cardiologist
- Dr Uma Malhotra – Infectious Disease
- Dr F Patricia McEachrane-Gross – Preventative & Family Medicine
- Dr Mythili Ramachandran – Internal Medicine
- Dr Andrea Veatch – Oncologist
See Speaker Bios
See List of Supporting Physicians
Schedule of events:
|6:50 – 7:00pm
||Amanda Strombom, President, Vegetarians of Washington
|7:00 – 7:15pm
||Dr Uma Krishnan, Cardiologist
||Coronary Artery Disease and Hypercholesterolemia
|7:15 – 7:30pm
||Dr Mythili Ramachandran, Internal Medicine
||Type II Diabetes
|7:30 – 7:45pm
||Dr Andrea Veatch, Oncologist
|7:45 – 8:00pm
||Dr George Lee, Family Medicine
|8:00 – 8:15pm
||Dr Chan Hwang, Physiatrist
||Crohn’s Disease and Rheumatoid Arthritis
|8:15 – 8:30pm
||Dr Helmuth Fritz, Internal Medicine
||Chronic Kidney Disease
|8:30 – 8:45pm
||Dr Uma Malhotra, Infectious Disease
||Antibiotic Resistance and Zoonoses
|8:45 – 9:00pm
||Dr F Patricia McEachrane-Gross, Preventive and Family Medicine
||Plant-Based Diets in Clinical Practice
Video of complete seminar:
This activity has been planned and implemented in accordance with accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Washington State Medical Association and Vegetarians of Washington. The WSMA is accredited by the ACCME to provide continuing medical education for physicians.
The WSMA designates this live activity for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity meets the criteria for up to 2 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
We are delighted to announce that our comprehensive review article on the prevention and treatment of Type 2 Diabetes Mellitus with a Plant-Based Diet was recently published in the peer-reviewed Endocrinology and Metabolism International Journal.
Here’s the published article as a pdf.
The Prevention and Treatment of Type 2 Diabetes Mellitus with a Plant-Based Diet
Open Letter To the Editor-in-Chief, Journal of the American College of Cardiology
October 27, 2017
Dear Dr. Fuster,
In your recent update to the Expert Consensus Decision Pathway, (1) no specific mention was made of a safe and efficacious non-statin therapy, the plant-based diet.
Vegetarian and vegan diets can be very efficacious in reducing serum cholesterol and, importantly, LDL. Studies have shown that those following a plant-based diet have significantly lower total cholesterol and LDL levels. (2)
This article is also available in printable pdf form: Colon Cancer Prevention with a Plant-Based Diet
I. Executive Summary
It has long been known that vegetarians have a substantially reduced risk of colon cancer. Several studies have shown that vegetarians have a reduced risk of colon cancer of 46%-88%, and, as might be expected, a 54% reduced risk of colon adenoma, plus a 200% reduced risk of advanced adenoma. Vegetarians also have a lower prevalence of risk factors for colon cancer. These include a much lower risk of hyperinsulinemia secondary to metabolic syndrome, lower risk of obesity, and a much lower risk of Crohn’s disease. Vegetarians also have lower levels of CRP (cardio reactive protein) indicating a lower inflammatory status. This has also been correlated with a better prognosis for colon cancer.
This is a letter we just had to write. We sent a fully documented Letter to Editor of Endocrine Practice Journal, concerning a published algorithm for the treatment of Type II Diabetes. We were delighted that our letter was published – see Published Letter to Endocrine Practice – in their June 2017 issue, along with a Response from authors of the algorithm.